Connor, Clark & Lunn Investment Management (CC&L)’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
|
|||||
|
2025
Q1 | $3.15M | Buy |
|
|||||
|
2024
Q4 | $1.8M | Buy |
|
|||||
|
2024
Q3 | $1.07M | Buy |
|
|||||
|
2024
Q2 | $386K | Sell |
|
|||||
|
2024
Q1 | $534K | Buy |
|
|||||
|
2023
Q4 | $541K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $180K | Sell |
|
|||||
|
2022
Q4 | $902K | Sell |
|
|||||
|
2022
Q3 | $1.37M | Sell |
|
|||||
|
2022
Q2 | $2.32M | Buy |
|
|||||
|
2022
Q1 | $291K | Buy |
|